Concepedia

James B. Moberly

JB

Statistics

Publications

33

Citations

1.2K

H-Index

20

Active since

1989

Affiliations

Baxter (United States)(Current)

Daiichi Sankyo (United States)

Pfizer (United States)

Daiichi Sankyo (Germany)

Oklahoma Medical Research Foundation

James B. Moberly is an author at Baxter (United States) specializing in biochemistry, medicine, and dialysis.

Publications per year

1989–2015

33

Publications

33

Oleic acid stimulation of apolipoprotein B secretion from HepG2 and Caco-2 cells occurs post-transcriptionally

James B. Moberly, Thomas Cole, David Alpers et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1990 · 149 citations

Life Sciences, Biochemistry, Molecular Biology +13

Pharmacokinetics of icodextrin in peritoneal dialysis patients

James B. Moberly, Salim Mujais, Todd W.B. Gehr et al. · Kidney International · 2002 · 100 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +12

Inhibition of apolipoprotein B and triglyceride secretion in human hepatoma cells (HepG2).

Mehrdad Haghpassand, Donald E. Wilder, James B. Moberly · Journal of Lipid Research · 1996 · 98 citations · Full text

Life Sciences, Biochemistry, Pharmacology +14

Apolipoprotein B-containing lipoproteins in renal failure: The relation to mode of dialysis

Per-Ola Attman, Ola Samuelsson, James B. Moberly et al. · Kidney International · 1999 · 85 citations

Medicine, Biochemistry, Nephrology +13

Low whole blood and erythrocyte levels of glutathione in hemodialysis and peritoneal dialysis patients

Edward Alsworth Ross, L Koo, James B. Moberly · American Journal of Kidney Diseases · 1997 · 80 citations

Medicine, Biochemistry, Nephrology +16

1–5 of 33